XERODERMAPIGMENTOSUM: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC ASPECTS

K. Benlaaguid; O. El Atiqi; Md.El Amrani; Y. Benchamkha

doi:10.21474/IJAR01/17363

15 Aug 2023 Vol. 11 (08) pp. 70-75 DOI: 10.21474/IJAR01/17363

XERODERMAPIGMENTOSUM: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC ASPECTS

K. Benlaaguid, O. El Atiqi, Md.El Amrani and Y. Benchamkha

In the Plastic Surgery Department CHU Med VI -Marrakech.

16 Downloads 79 Views

Download Full Paper (PDF)

Abstract

Xeroderma Pigmentosum (XP) is a rare and disabling genetic dermatosis that was first described in 1874. It is characterized by photo-induced cutaneous alterations, often associated with ocular lesions and sometimes with neurological involvement. The transmission of XP is on an autosomal recessive mode, and it is relatively frequent in countries with high consanguinity rates and large family sizes, such as those in the Maghreb region. This study aims to present an epidemiological, clinical, and histological profile of XP patients treated in the plastic surgery department in southern Morocco, reflecting the regions epidemiological reality and specifying the modalities of oncologic and reparative surgical treatment.

How to Cite This Article

K. Benlaaguid, O. El Atiqi, Md.El Amrani and Y. Benchamkha (2023); XERODERMAPIGMENTOSUM: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC ASPECTS, International Journal of Advanced Research (IJAR), 11 (08), 70-75, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/17363

Corresponding Author

KHADIJA BENLAAGUID
In the plastic surgery department CHU Med VI -Marrakech.
Morocco

Article Analytics

This work is licensed under a Creative Commons Attribution 4.0 International License.